828 / 1544
Final Remarks
- HL is a curable disease with different options in terms of
initial therapy
- Therapy should be individualized on the basis of
patients’s age and presentation
- Ideally, all patients should be seen together with hemato-
oncologist with the aim to discuss the best strategy
- Highly conformal techniques are feasible and might offer
a theoretical benefit over classical 3D approaches
- Future studies are needed to fully understand the
changes in toxicity expected from modern radiotherapy
03/01/13